The goal of this project is to apply biomarkers of exposures and outcomes that have been developed thus far in the UC Davis Superfund laboratories to human populations with likely exposures to hazardous substances so as to provide laboratory/biologic assessment of exposures and health outcomes. This project is timely at this stage of the UC Davis Superfund effort in taking assay techniques that have been developed here into a real-lifer human setting to provide both practical information about the feasibility of such approaches as well as objective data about the likelihood of exposure of human populations to toxicants of interest to Superfund and the relation of such exposures ti adverse health effects in humans. Specifically the aims of this project are: a) evaluate the adverse human health effects, particularly neurologic and neurobehavioral effects, or organophosphate (OP) exposure in children in a farmworker community using monthly urine samples from mothers (including farmworkers and non-farmworkers) and their children to assess (OP) metabolites, such as glucuronides of Ops; b) to determine the prevalence of exposure and compare immunoassay to gas chromatography results; c) to evaluate the likely routes of exposure; d) to evaluate the relation of potential exposure to environmental endocrine disruptors and other potentially hazardous exposures to adverse reproductive and other human health effects in a residential community adjacent to a local Superfund site; and e) to compare thyroid hormone levels in opportunistic blood samples and treatment for thyroid disorders of household members who are likely and those who are unlikely to be exposed. This project will also provide epidemiologic field studies to examine the role of exposure to hazardous environmental substances in increasing the risk of adverse human health effects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Hazardous Substances Basic Research Grants Program (NIEHS) (P42)
Project #
2P42ES004699-14
Application #
6333686
Study Section
Special Emphasis Panel (ZES1-MAO-A (G2))
Project Start
1987-09-30
Project End
2005-03-31
Budget Start
Budget End
Support Year
14
Fiscal Year
2000
Total Cost
$165,230
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Taha, Ameer Y; Hennebelle, Marie; Yang, Jun et al. (2018) Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid. Prostaglandins Leukot Essent Fatty Acids 138:71-80
Hill 3rd, Thomas; Rice, Robert H (2018) DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate. Toxicol In Vitro 46:257-264
Kodani, Sean D; Wan, Debin; Wagner, Karen M et al. (2018) Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega 3:14076-14086
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Napimoga, M H; Rocha, E P; Trindade-da-Silva, C A et al. (2018) Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption. J Periodontal Res 53:743-749
Blöcher, René; Wagner, Karen M; Gopireddy, Raghavender R et al. (2018) Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain. J Med Chem 61:3541-3550
Hao, Lei; Kearns, Jamie; Scott, Sheyenne et al. (2018) Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther 365:467-475

Showing the most recent 10 out of 1149 publications